Indications for DEXYCU:
Treatment of postoperative inflammation.
Give 0.005mL intraocularly in the posterior chamber at the end of ocular surgery.
Glaucoma. May delay healing and increase incidence of bleb formation. Active viral diseases of the cornea and conjunctiva, epithelial herpes simplex keratitis, vaccinia, varicella, mycobacterial infection of the eye, and fungal disease of ocular structures: not recommended. May mask or exacerbate existing infections. Phakic patients. Monitor IOP and for secondary ocular infections in prolonged therapy. Pregnancy. Nursing mothers.
Increased IOP, corneal edema, iritis; ocular perforation, posterior subcapsular cataracts.
Generic Drug Availability:
Kit—1 (w. supplies)